Publications by authors named "Mathilde Vankelegom"
J Manag Care Spec Pharm
December 2023
Article Synopsis
- Nirmatrelvir/ritonavir (NMV/r) is a treatment for mild-to-moderate COVID-19 in high-risk adults and has also been approved for certain pediatric patients by the FDA.
- The study aims to evaluate the annual budget impact of NMV/r within a US commercial health plan during the Omicron variant's prevalence.
- Results show that NMV/r could potentially reduce hospitalizations significantly, leading to a total budget impact of approximately $2.7 million, with additional cost savings when considering various post-COVID conditions.
